https://www.sciencedirect.com/science/article/pii/S1083879119304495#:~:text=Steroid%2Drefractory%20aGVHD%20was%20defined,after%20completion%20of%20steroid%20taper.
https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2141.2012.09129.x
https://journals.sagepub.com/doi/full/10.1177/2040620713489842
Adding "All enrolled subjects in this trial must receive corticosteroids at a minimum dose of oral prednisone 2 mg/kg/day (or methylprednisolone 1.6 mg/kg/day IV) as therapy for aGvHD for at least for 72 hours post enrollment" is in my opinion CYP's approach to standardise the P2 trial and is in line with current first-line therapies for newly diagnosed patients with high-risk aGvHD.
The above is also in line with other clinical trials (past and present) for newly diagnosed patients with high-risk aGvHD:
https://www.sciencedirect.com/science/article/pii/S1083879109001530
https://clinicaltrials.gov/ct2/show/NCT04397367
https://clinicaltrials.gov/ct2/show/NCT01002742
The desperation displayed by the lack of any meaningful content, cock-eyed-"IMHO"-conclusions - in attempts to discredit a stock that is currently valued at a MC of just over A$42 million - by investors of MSB is well received by the way. Especially the frequency of these poor attempts show how much CYP is on your minds, despite our current SP of A$0.29. I take that as a compliment and for that I thank you.
- Forums
- ASX - By Stock
- CYP
- Ann: FDA Clears Cynata IND for Phase 2 Trial in GvHD
CYP
cynata therapeutics limited
Add to My Watchlist
0.00%
!
16.5¢

Ann: FDA Clears Cynata IND for Phase 2 Trial in GvHD, page-64
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M |
Open | High | Low | Value | Volume |
17.0¢ | 17.0¢ | 16.0¢ | $29.18K | 176.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 66467 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 65000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 66467 | 0.160 |
4 | 181490 | 0.155 |
5 | 318045 | 0.150 |
4 | 81775 | 0.145 |
4 | 307863 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 65000 | 1 |
0.185 | 35419 | 2 |
0.190 | 114978 | 3 |
0.195 | 5764 | 1 |
0.200 | 55400 | 2 |
Last trade - 15.59pm 25/07/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online